Healthcare -
Drug Manufacturers - Specialty & Generic - NYSE - US
$ 6.83
-8.69 %
$ 370 M
Market Cap
-1.75
P/E
EBS - OPERATING EXPENSES
Operating Expenses EBS - Emergent BioSolutions Inc.
1.04 B
LAST VALUE
27.63%
2 YEAR CAGR
23.04%
5 YEAR CAGR
17.52%
10 YEAR CAGR